Company intelligence / Profile preview

Devintec Pharma

Lugano, Ticino, Switzerlanddevintecpharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Devintec has developed several patented, clinically proven substance-based medical devices using its proprietary DevinPro™ technology. These products have demonstrated efficacy comparable to standard pharmaceutical treatments in indications such as atopic dermatitis, IBS, constipation, bloating, and psoriasis. The company emphasizes non-pharmaceutical solutions with strong safety profiles.

Therapeutic areas: GastroenterologyDermatology
Modalities: Substance-based medical deviceNon-pharmaceutical therapy (barrier-forming technology)
Industry: Therapeutic Medical Devices

Partnerships

B2B outlicensing partnerships globally

Beyond the preview

Go deeper on Devintec Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Devintec Pharma.

Explore the full profile